Radiotherapy Reprograms CCR8⁺ Regulatory T Cells via REL-NF-κB to Enforce Spatial Immune Exclusion in Hepatocellular Carcinoma.
- 1Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- 2Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- 3Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Abstract
Radiotherapy is increasingly incorporated into the treatment of hepatocellular carcinoma (HCC), but adaptive immunosuppressive remodeling of the tumor microenvironment can limit efficacy. We integrated public bulk, single-cell, and spatial transcriptomic cohorts with a murine single-cell atlas, paired human radiotherapy specimens, and functional murine studies. High intratumoral regulatory T cell (Treg) infiltration was associated with poor prognosis across two cohorts. Analyses of single cells identified a CCR8⁺ Treg state that was enriched in advanced tumors, exhibited enhanced suppressive features, and was conserved across species. Spatial analyses showed that CCR8⁺ Tregs accumulated in peritumoral regions enriched in myeloid cells and fibrotic stroma, where CD8⁺ T cell infiltration was limited. Hypofractionated radiotherapy expanded suppressive CCR8⁺ Tregs, while radiation enhanced CCL1 secretion by M2-like tumor-associated macrophages (TAMs), providing a recruitment signal. Mechanistically, REL knockdown, chromatin immunoprecipitation, and promoter reporter assays demonstrated that radiation activates REL, which directly binds to and transactivates the CCR8 promoter. CCR8 blockade enhanced radiotherapy efficacy, reduced suppressive Treg features, and increased cytotoxic CD8⁺ T cell activity. These findings identify a REL-NF-κB-CCR8 axis as a mediator of immune adaptation following radiotherapy and support combination therapies targeting CCR8 in HCC.
Related
- Same organ, divergent immunity: T-cell exhaustion versus stromal exclusion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
- Portal Vein Tumor Thrombus in Hepatocellular Carcinoma: An Immune Sanctuary Driving Immune Exclusion and Therapeutic Resistance.
- Efficacy and Safety of Sequential Radiotherapy and Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Single-Center PSM Retrospective Cohort Study.
- A conditional, myeloid-cell specific estrogen receptor α deletion reprograms the liver immune microenvironment and impedes the growth of colon carcinoma liver metastases
- Ablative ultra-hypofractionated radiotherapy with surgical GI exclusion as a “functional spacer” for pancreatic cancer: a phase I safety and feasibility study
BibTeX
@article{chen2026radiotherapy,
title = {{Radiotherapy Reprograms CCR8⁺ Regulatory T Cells via REL-NF-κB to Enforce Spatial Immune Exclusion in Hepatocellular Carcinoma.}},
author = {Huanliang Chen and Shuxuan Wang and Bufu Tang and Yanyan Lin and Pan Zhou and Jiaoyang Yang and Qian-Qian Zhao and Zhao-Chong Zeng},
journal = {International journal of biological sciences},
year = {2026},
month = sep,
doi = {10.7150/ijbs.136364},
url = {https://europepmc.org/article/MED/42910245},
note = {CC BY},
}
RIS
TY - JOUR
TI - Radiotherapy Reprograms CCR8⁺ Regulatory T Cells via REL-NF-κB to Enforce Spatial Immune Exclusion in Hepatocellular Carcinoma.
AU - Huanliang Chen
AU - Shuxuan Wang
AU - Bufu Tang
AU - Yanyan Lin
AU - Pan Zhou
AU - Jiaoyang Yang
AU - Qian-Qian Zhao
AU - Zhao-Chong Zeng
PY - 2026
DA - 2026/09/24
JO - International journal of biological sciences
DO - 10.7150/ijbs.136364
UR - https://europepmc.org/article/MED/42910245
AB - Radiotherapy is increasingly incorporated into the treatment of hepatocellular carcinoma (HCC), but adaptive immunosuppressive remodeling of the tumor microenvironment can limit efficacy. We integrated public bulk, single-cell, and spatial transcriptomic cohorts with a murine single-cell atlas, paired human radiotherapy specimens, and functional murine studies. High intratumoral regulatory T cell (Treg) infiltration was associated with poor prognosis across two cohorts. Analyses of single cells identified a CCR8⁺ Treg state that was enriched in advanced tumors, exhibited enhanced suppressive features, and was conserved across species. Spatial analyses showed that CCR8⁺ Tregs accumulated in peritumoral regions enriched in myeloid cells and fibrotic stroma, where CD8⁺ T cell infiltration was limited. Hypofractionated radiotherapy expanded suppressive CCR8⁺ Tregs, while radiation enhanced CCL1 secretion by M2-like tumor-associated macrophages (TAMs), providing a recruitment signal. Mechanistically, REL knockdown, chromatin immunoprecipitation, and promoter reporter assays demonstrated that radiation activates REL, which directly binds to and transactivates the CCR8 promoter. CCR8 blockade enhanced radiotherapy efficacy, reduced suppressive Treg features, and increased cytotoxic CD8⁺ T cell activity. These findings identify a REL-NF-κB-CCR8 axis as a mediator of immune adaptation following radiotherapy and support combination therapies targeting CCR8 in HCC.
SN - 1449-2288
ER -